Sara-Bay Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Sell |
14,177
-429
| -3% | -$79.6K | 0.94% | 12 |
|
|
2025
Q1 | $3M | Buy |
14,606
+977
| +7% | +$201K | 1.32% | 12 |
|
|
2024
Q4 | $2.4M | Buy |
13,629
+247
| +2% | +$43.5K | 0.89% | 14 |
|
|
2024
Q3 | $2.64M | Sell |
13,382
-408
| -3% | -$80.6K | 0.96% | 17 |
|
|
2024
Q2 | $2.37M | Buy |
13,790
+466
| +3% | +$79.9K | 0.96% | 16 |
|
|
2024
Q1 | $2.41M | Buy |
13,324
+857
| +7% | +$155K | 1.08% | 16 |
|
|
2023
Q4 | $1.93M | Buy |
12,467
+7
| +0.1% | +$1.09K | 0.94% | 17 |
|
|
2023
Q3 | $1.86M | Sell |
12,460
-126
| -1% | -$18.8K | 0.94% | 16 |
|
|
2023
Q2 | $1.7M | Buy |
12,586
+85
| +0.7% | +$11.5K | 0.82% | 17 |
|
|
2023
Q1 | $1.99M | Sell |
12,501
-861
| -6% | -$137K | 1.01% | 16 |
|
|
2022
Q4 | $2.16M | Sell |
13,362
-53
| -0.4% | -$8.56K | 1.21% | 15 |
|
|
2022
Q3 | $1.8M | Sell |
13,415
-82
| -0.6% | -$11K | 1% | 18 |
|
|
2022
Q2 | $2.08M | Sell |
13,497
-26
| -0.2% | -$4K | 1.01% | 19 |
|
|
2022
Q1 | $2.19M | Buy |
13,523
+489
| +4% | +$79.3K | 0.87% | 17 |
|
|
2021
Q4 | $1.77M | Buy |
13,034
+2,624
| +25% | +$355K | 0.53% | 20 |
|
|
2021
Q3 | $1.12M | Buy |
10,410
+46
| +0.4% | +$4.96K | 0.44% | 21 |
|
|
2021
Q2 | $1.17M | Buy |
10,364
+1,155
| +13% | +$130K | 0.44% | 22 |
|
|
2021
Q1 | $997K | Buy |
9,209
+2,411
| +35% | +$261K | 0.41% | 23 |
|
|
2020
Q4 | $728K | Buy |
6,798
+1,796
| +36% | +$192K | 0.33% | 26 |
|
|
2020
Q3 | $438K | Buy |
5,002
+105
| +2% | +$9.19K | 0.24% | 44 |
|
|
2020
Q2 | $484K | Buy |
+4,897
| New | +$484K | 0.28% | 38 |
|